Latest Regulatory Progress News

Medical Developments International reported a strong start to FY26 with significant revenue growth driven by increased Penthrox volumes and pricing improvements in Australia, alongside steady European demand and progress on paediatric label approvals.

EVE Health Group has raised $1.1 million to accelerate the commercial rollout of its innovative pharmaceutical products Dyspro and Libbo, signaling strong investor confidence in its growth strategy.

Greenwing Resources has unveiled a scoping study for its Que River polymetallic project in Tasmania, outlining a low capital expenditure route to potentially generate A$63 million in cash flow within a year. The study leverages existing infrastructure and highlights significant exploration upside beneath existing pits.

Brazilian Critical Minerals Ltd advances permitting for its Ema rare earths project in Brazil, securing strong local government support and progressing key licence applications.

Bathurst Resources’ subsidiary Telkwa Mining has released an updated feasibility study for its Tenas Steelmaking Coal Project, confirming reserve validity and boosting project valuation despite significant cost inflation.

Locksley Resources has gained critical regulatory approval and secured contractors to advance its Mojave Project, accelerating exploration of antimony and rare earth elements in California.

Echo IQ reports a remarkable 153% increase in echocardiogram processing through its EchoSolv AS platform in the US, with a Mayo Clinic validation study nearing completion ahead of a critical FDA submission. The company is also advancing European market entry and strengthening its advisory team to accelerate global growth.

Global Uranium and Enrichment Limited reports promising drilling outcomes and regulatory progress at its Pine Ridge Uranium Project in Wyoming, reinforcing its potential amid a strengthening uranium market.

Carnavale Resources’ updated Scoping Study for the Kookynie Gold Project reveals a doubling in project value and robust economics, supporting a five-year mine life with 93,000 ounces of gold production.

Audalia Resources has completed a $500,000 placement to a sophisticated investor, issuing 20 million shares to fund critical development stages at its Medcalf Project. The capital injection aims to advance mining design, permits, and approvals while bolstering working capital.

OzAurum Resources has launched a targeted drilling campaign at its Mulgabbie North Gold Project, aiming to expand high-grade zones and advance feasibility studies amid record gold prices.

Anteris Technologies has gained shareholder approval for an ASX waiver allowing flexible capital raising and updated its PARADIGM trial timeline, now set to begin patient enrolment in Q4 2025 after addressing FDA requests.